SC 13G

Company

Spyre Therapeutics, Inc.

Filed

December 13, 2023

Accession Number

0001193125-23-294297

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →